Allergan confirmed on Thursday that it was in preliminary discussions to sell itself to Pfizer, potentially setting up a blockbuster merger of two drug makers as the industry undergoes an enormous wave of consolidation.
A takeover of Allergan, which manufactures Botox, would be the biggest deal of the year, given the company’s market value of $113 billion as of Thursday morning.
20:37 Brazil grants antitrust approval for FMC Technologies, Technip merger20
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle17
14:47 Gambian president said he would rule for a ‘billion years.’ He just lost reelection15
21:05 Starbucks Chief Howard Schultz to Step Down Next Year12